Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jiřina Martínková"'
Autor:
Renata Černá Pařízková, Jiřina Martínková, Eduard Havel, Petr Šafránek, Milan Kaška, David Astapenko, Jan Bezouška, Jaroslav Chládek, Vladimír Černý
Publikováno v:
Critical Care, Vol 25, Iss 1, Pp 1-9 (2021)
Abstract Background Meropenem dosing for septic critically patients is difficult due to pathophysiological changes associated with sepsis as well as supportive symptomatic therapies. A prospective single-center study assessed whether fluid retention
Externí odkaz:
https://doaj.org/article/a76aa8feec604a168cc8ab090189481a
Autor:
Stanislav Mičuda, Martin Hodač, Petr Pařízek, Miloslav Pleskot, Luděk Šišpera, Jaroslav Cerman, Jana Maláková, Jiřina Martínková, Vladimír Pidrman
Publikováno v:
Acta Medica, Vol 43, Iss 3, Pp 95-101 (2000)
The present work was designed to determine whether the individual differences in pharmacokinetics and pharmacodynamics of amiodarone and its N-desethyl metabolite are related to cytochrome CYP3A metabolizer status. Methods: 12 cardiac patients with i
Externí odkaz:
https://doaj.org/article/eb60fc5d97cb471782cf9d559d64cee9
Autor:
Jiřina, Martínková
Publikováno v:
Klinicka mikrobiologie a infekcni lekarstvi. 21(1)
The review article interprets recommendations for treating methicillin-resistant Staphylococcus aureus (MRSA) infections with vancomycin. These stem from a 2009 consensus followed by numerous preclinical and clinical studies carried out until now. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d521f1e5f32166e45bc14c3ea2603094
https://pubmed.ncbi.nlm.nih.gov/26098489
https://pubmed.ncbi.nlm.nih.gov/26098489
Autor:
Jiří, Grim, Miloš, Hroch, Hroch, Miloš, Jaroslav, Chládek, Chládek, Jaroslav, Jiří, Petera, Petera, Jiří, Jiřina, Martínková, Martínková, Jiřina
Publikováno v:
Clinical pharmacokinetics. 54(5)
This study estimated patients' early response following neoadjuvant chemoradiotherapy (CHRT) of locally advanced rectal cancer based on 5-fluorouracil (5-FU). The target was to achieve pathological complete response (pCR; residual disease-free stage)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82e3273b9572aa706d2a924244dd01d8
https://pubmed.ncbi.nlm.nih.gov/25791896
https://pubmed.ncbi.nlm.nih.gov/25791896
Publikováno v:
Clinical Pharmacokinetics; May2015, Vol. 54 Issue 5, p503-515, 13p, 8 Charts, 3 Graphs
Autor:
Milan Kaska, Eduard Havel, Iva Selke-Krulichova, Petr Safranek, Jan Bezouska, Jirina Martinkova
Publikováno v:
Biomedical Papers, Vol 162, Iss 3, Pp 219-226 (2018)
Aims: Critically ill patients undergoing aggressive fluid resuscitation and treated empirically with hydrosoluble time-dependent beta-lactam antibiotics are at risk for sub-therapeutic plasma concentrations. The aim of this study was to assess the im
Externí odkaz:
https://doaj.org/article/1dbf3825358b4b0aacf4f2cb0d1ca7da